Iron overload and myelodysplastic syndromes.

By Rose C.   Cambier N.   Mahieu M.   Ernst O.   Fenaux P.  

Transfusion Clinique et Biologique, Vol. 8, Iss. 5, 2001-10 ,pp. : 422-432

Elsevier

Access to resources Recommend Favorite

Cytogenetic features in myelodysplastic syndromes

By Haase Detlef  

Annals of Hematology, Vol. 87, Iss. 7, 2008-07 ,pp. : 515-526

Springer Publishing Company

Access to resources Recommend Favorite

Gene expression profiling in the myelodysplastic syndromes

By Pellagatti Andrea   Fidler Carrie   Wainscoat James S.   Boultwood Jacqueline  

Hematology, Vol. 10, Iss. 4, 2005-08 ,pp. : 281-287

Maney Publishing

Access to resources Recommend Favorite

Activity of the caspase-3/CPP32 enzyme is increased in ''early stage'' myelodysplastic syndromes with excessive apoptosis, but caspase inhibition does not enhance colony formation in vitro

By Bouscary D.   Chen Y.L.   Guesnu M.   Picard F.   Viguier F.   Lacombe C.   Dreyfus F.   Fontenay-Roupie M.  

Experimental Hematology, Vol. 28, Iss. 7, 2000-07 ,pp. : 784-791

Elsevier

Access to resources Recommend Favorite

Increased apoptosis of bone marrow cells and preserved proliferative capacity of selected progenitors predict for clinical response to anti-inflammatory therapy in myelodysplastic syndromes

By Novitzky N.   Mohamed R.   Finlayson J.   du Toit C.  

Experimental Hematology, Vol. 28, Iss. 8, 2000-08 ,pp. : 941-949

Elsevier

Access to resources Recommend Favorite